| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 18.68B | 17.89B | 17.39B | 14.86B | 12.57B |
| Gross Profit | 2.88B | 3.01B | 2.91B | 2.40B | 2.33B |
| EBITDA | 1.75B | 1.40B | 1.54B | 1.05B | 1.23B |
| Net Income | 857.42M | 785.08M | 605.37M | 547.50M | 846.27M |
Balance Sheet | |||||
| Total Assets | 18.32B | 17.69B | 18.08B | 16.85B | 14.37B |
| Cash, Cash Equivalents and Short-Term Investments | 6.45B | 5.79B | 5.69B | 5.07B | 5.51B |
| Total Debt | 511.11M | 803.52M | 1.73B | 1.85B | 1.32B |
| Total Liabilities | 9.60B | 9.15B | 9.86B | 8.98B | 7.00B |
| Stockholders Equity | 7.96B | 7.79B | 7.41B | 7.12B | 7.02B |
Cash Flow | |||||
| Free Cash Flow | 1.47B | 1.15B | 933.16M | 241.48M | 609.28M |
| Operating Cash Flow | 1.59B | 1.47B | 1.44B | 695.28M | 1.02B |
| Investing Cash Flow | -291.63M | -503.29M | -377.53M | -140.77M | -301.51M |
| Financing Cash Flow | -837.96M | -651.45M | -717.25M | -720.42M | -778.69M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$17.53B | 4.67 | 15.52% | 4.43% | 6.54% | 3.26% | |
74 Outperform | HK$6.46B | 10.17 | 37.09% | 6.94% | 21.11% | 9.61% | |
71 Outperform | HK$13.46B | 15.46 | 11.18% | 2.78% | -0.95% | 14.89% | |
69 Neutral | HK$13.23B | 10.01 | 23.68% | 3.82% | ― | ― | |
66 Neutral | HK$19.51B | 30.82 | 3.73% | 4.94% | 7.23% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
51 Neutral | HK$12.32B | 11.52 | 74.40% | ― | 4.74% | -21.33% |